OPT News: Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference - 6th Mar 2023, 10:00pm

[annb0t]

Opthea Limited

MELBOURNE, Australia, March 06, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Chief Executive Officer, will participate in a fireside chat at Oppenheimer’s 33rd Annual Healthcare Conference being held virtually on March 13-15, 2023.

Dr. Baldwin’s conversation with Ha...

>>> Read more: Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference